Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World

被引：0
|
作者：
Chen, C. [1 ]
机构：
[1] Zunyi Med Univ, Affiliated Hosp, Zunyi, Guizhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer; Neoadjuvant therapy; PD-1; inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-24
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
    Chen, Lanyi Nora
    Wei, Alexander Z.
    Shu, Catherine A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [42] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [43] Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings
    Yoneda, Taro
    Sone, Takashi
    Koba, Hayato
    Shibata, Kazuhiko
    Suzuki, Junya
    Tani, Mayuko
    Nishitsuji, Masaru
    Nishi, Koichi
    Kobayashi, Takafumi
    Shirasaki, Hiroki
    Araya, Tomoyuki
    Kita, Toshiyuki
    Kase, Kazumasa
    Yamamura, Kenta
    Terada, Nanao
    Nishikawa, Shingo
    Tambo, Yuichi
    Kimura, Hideharu
    Kasahara, Kazuo
    CLINICAL LUNG CANCER, 2022, 23 (06) : 467 - 476
  • [44] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
  • [45] Neoadjuvant therapy for non-small cell lung cancer
    Gandara, DR
    Lara, PN
    Goldberg, Z
    Roberts, P
    Lau, DHM
    ANTI-CANCER DRUGS, 2001, 12 : S5 - S9
  • [46] Non-small cell lung cancer neoadjuvant chemotherapy: the benefits of gemcitabine
    Van Zandwijk, N
    ANTI-CANCER DRUGS, 2001, 12 : S15 - S19
  • [47] Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study
    Qi Wei
    Taibing Deng
    Junhua Wu
    Hao Zeng
    Chang Qi
    Sihan Tan
    Yuanyuan Zhang
    Qin Huang
    Xin Pu
    Weiguo Xu
    Weimin Li
    Panwen Tian
    Yalun Li
    BMC Cancer, 24
  • [48] Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
    Hu, Yan
    Ren, Siying
    Yang, Lulu
    Tong, Zhongyi
    Wang, Ruoyao
    Han, Wei
    Zeng, Chao
    Li, Jina
    Xiao, Peng
    Wang, Li
    Yu, Fenglei
    Liu, Wenliang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [49] Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study
    Wei, Qi
    Deng, Taibing
    Wu, Junhua
    Zeng, Hao
    Qi, Chang
    Tan, Sihan
    Zhang, Yuanyuan
    Huang, Qin
    Pu, Xin
    Xu, Weiguo
    Li, Weimin
    Tian, Panwen
    Li, Yalun
    BMC CANCER, 2024, 24 (01)
  • [50] Bronchiolitis obliterans syndrome associated with an immune checkpoint inhibitor in a patient with non-small cell lung cancer
    Takeda, Kenichiro
    Miwa, Hideki
    Kono, Masato
    Hirama, Ryutaro
    Oshima, Yuiko
    Mochizuka, Yasutaka
    Tsutsumi, Akari
    Miki, Yoshihiro
    Hashimoto, Dai
    Nakamura, Hidenori
    RESPIRATORY MEDICINE CASE REPORTS, 2023, 42
12345